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per year. Completeness of ascertainment as calculated by 
the capture-recapture method amounted to 93.6%. At the 
time of diagnosis, 27.1% of children with type 1 diabetes had 
ketoacidosis, 1.5% had a blood pH  ! 7.0, and 1.1% were un-
conscious.  Conclusion: The registry provided data about the 
incidence rates and clinical presentation of childhood diabe-
tes in a defined German population. We observed higher in-
cidence rates compared to previous surveys. 
 Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Type 1 diabetes is one of the most frequent chronic 
metabolic disorders in children and adolescents. A global 
rise in the incidence of type 1 diabetes in children and 
adolescents has been reported over the past decades  [1–7] . 
Putative causes explaining this increase are still not yet 
clarified. Mean incidence rates of type 1 diabetes vary 
considerably depending on the geographic region  [2–7] . 
Particularly China and South American countries have 
very low incidence rates. Apart from regions with low to 
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 Abstract 
 Aims: The Childhood Diabetes Registry in Saxony, Germany, 
examined the incidence and metabolic characteristics of 
childhood diabetes.  Methods: In the federal state of Saxony, 
newly diagnosed cases of diabetes in children and adoles-
cents aged less than 15 years were registered continuously 
from 1999 until 2008. Family history, date of diagnosis, clini-
cal and laboratory parameters were obtained. Reported cas-
es were ascertained by public health departments as an in-
dependent data source and verified using the capture-
recapture method.  Results: A total of 865 children and 
adolescents with newly diagnosed diabetes were registered 
in Saxony. About 96% of them were classified as having type 
1 diabetes, 0.6% had type 2 diabetes, 2.4% had maturity-
onset diabetes of the young (MODY), and 1.4% had other 
types of diabetes. The age-standardized incidence rate of 
type 1 diabetes was estimated at 17.5 per 100,000 children 
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intermediate incidence rates ranging between 5 and 20 
per 100,000 children/adolescents per year, there are areas 
with incidence rates as high as 27.5–42.9 per 100,000 chil-
dren/adolescents per year. Northern European countries 
such as Finland and Sweden, and Canada have the high-
est incidence rates ranging between 30 and 40 per 100,000 
children/adolescents per year  [2–7] . Incidence rates of 
countries in Central Europe (with the exception of Sar-
dinia) vary from 8 to 18 per 100,000 children/adolescents 
per year  [2, 4, 5, 8–11] . The incidence for type 1 diabetes 
in German children aged 0–14 years was estimated at 13 
per 100,000 per year for 1987–1998 and at 15.5 per 100,000 
per year for 1999–2003. This incidence was estimated 
from a registry undertaken in the southwestern part of 
Germany, a region covering about 10% of the total Ger-
man area  [12–14] . The registry of the former German 
Democratic Republic which was run from 1960 until 
1989 reported incidence rates between 7.4 and 13.8 per 
100,000 per year  [15] .
 Previously perceived as disease of the elderly, most re-
cently children and adolescents are more frequently af-
fected by type 2 diabetes. The number of type 2 diabetes 
cases diagnosed is subject to regional aspects and ethnic 
origin. Type 2 diabetes is more frequently found in Afri-
can-American children and adolescents and in offspring 
of Pima Indians compared to children and adolescents of 
Caucasian origin  [16–19] . Epidemiological data on other 
types of diabetes in childhood is scare. Only a few data 
exist about the prevalence of maturity-onset diabetes of 
the young (MODY) in certain regions. Studies in Scandi-
navian countries estimate the prevalence of MODY at 2% 
on all diabetes cases and varying between 2 and 5% in 
relation to non-insulin-dependent diabetes cases  [16–19] .
 The Childhood Diabetes Registry of Saxony was estab-
lished to collect prospective epidemiological data on 
childhood diabetes in a defined German population. Fur-
thermore, it was to provide data on clinical and metabol-
ic characteristics of type 1 diabetes at the time of diagno-
sis. Considering the increasing incidence of childhood 
diabetes worldwide and evaluation of clinical and meta-
bolic characteristics of childhood diabetes, consecutive 
registries will provide the basis for more efficient socio-
economic and public health management in the future.
 Methods 
 Description of the Study Population 
 The Childhood Diabetes Registry of Saxony was established in 
1999 to consecutively register all children and adolescents with 
newly diagnosed diabetes aged less than 15 years and living in 
Saxony. Saxony is a federal state of Germany bordering Poland 
and the Czech Republic to the east. In Saxony, the population un-
der the age of 15 years decreased from 578,271 in 1999 to 445,523 
in 2008 with a minimum of 436,305 in 2005 (49% male, 51% fe-
male). These mid-year estimates were obtained from the statisti-
cal district department of Saxony (Federal State Department Sax-
ony).
 Data Collection 
 All 34 pediatric clinics and pediatric departments of Saxony 
participated in the registry. Diagnostic criteria for childhood dia-
betes were according to ISPAD criteria for children and adoles-
cents (ISPAD Clinical Practice Consensus Guidelines 2006–2007) 
 [16] . Regular meetings and professional certified education were 
offered to the participating pediatricians. Personal data (date of 
birth, gender, birth weight, municipality of residence), family his-
tory of type 1 diabetes, date of diagnosis, and clinical and bio-
chemical data at onset of diabetes were collected by a standard-
ized questionnaire. Date of diagnosis was defined as the date of 
the first insulin injection in the case of type 1 diabetes. For other 
types, diabetes was diagnosed when oral glucose tolerance test 
met the diagnostic criteria for diabetes (fasting plasma glucose of 
or above 7.0 mmol/l (126 mg/dl), or 2-hour plasma glucose of or 
above 11.1 mmol/l (200 mg/dl)) or repeated elevated random plas-
ma glucose levels of or above 11.1 mmol/l (200 mg/dl) were re-
corded  [16] . Pediatricians assessed clinical and biochemical pa-
rameters, duration of clinical signs and symptoms, and level of 
consciousness. Parameters such as blood glucose level, hemoglo-
bin A1c (HbA1c), pH, base excess (BE) and bicarbonate were mea-
sured at the time of hospital admission in the routine laboratory 
of the respective hospital. Ketoacidosis was defined as pH  ! 7.3, 
severe ketoacidosis was defined as pH  ! 7.1  [20] . Duration of hos-
pital stay was documented.
 The Childhood Diabetes Registry of Saxony was approved by 
the Ethical Committee of the Medical Faculty of the University of 
Leipzig and written informed consent was obtained from all par-
ents.
 Ascertainment of Cases 
 Completeness of ascertainment was assessed in collaboration 
with regional Public Health Departments of Aue, Chemnitzer 
Land, Dresden, Freiberg, Leipzig, Riesa-Grossenhain, Vogtland-
kreis, Weisseritzkreis, and Zittau, providing an independent data 
source. Public health departments performed school examina-
tions in children and adolescents at the age of 6, 11 and 15 years, 
and obtained information regarding medical history, chronic dis-
eases, medical treatment and the name and address of the treating 
pediatrician and hospital from the parents. The completeness of 
ascertainment was calculated according to the capture-recapture 
method  [21] .
 Statistical Analysis 
 Total as well as gender- and age-specific incidence rates per 
100,000 person-years were calculated for each calendar year. All 
incidence rates are age-standardized using the European standard 
population  [22] and represented as standardized incidence rates 
(SIRs) per 100,000 person-years in total as well as over time be-
tween two 5-year periods (first: 1999–2003, latest: 2004–2008). 
The 95% confidence intervals (CI) for SIRs are based on a normal 
approximation using standard errors of estimations. The Wald 
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test was used to compare the SIRs of the two time periods. Clinical 
data are presented as mean and standard deviation and CI. We 
employed the Kruskal-Wallis test to analyze differences between 
more than two groups. Student’s t test and variance analysis, with 
Tukey-adjusted multiple comparisons between estimated means, 
were performed to compare quantitative variables between groups. 
The   2 test was used to compare categorical variables. Statistical 
parameters were estimated using Microsoft Excel and SPSS pro-
gram 16.0. The level of significance was defined as   = 0.05.
 Results 
 A total of 865 children and adolescents aged 0–15 years 
were identified with newly diagnosed diabetes during the 
10-year observation period. Of those, 827 children and 
adolescents (95.6%) had type 1 diabetes (54.3% male, 
45.7% female) and 5 (0.6%) were classified as having type 
2 diabetes. A total of 33 children (3.8%) had other types 
of diabetes. Of these, 21 children (2.4%) had MODY 
which was confirmed by genetic analysis and 12 children 
(1.4%) had diabetes secondary to another disease, mostly 
cystic fibrosis. Completeness of ascertainment was esti-
mated at 93.6%.
 Incidence of Type 1 Diabetes 
 Age-SIR of type 1 diabetes per 100,000 person-years 
was estimated at 17.5 (95% CI 16.3–18.7) for the entire 
observation period. SIR increased significantly from 
15.7 (95% CI 14.2–17.3) per 100,000 person-years in the 
time period 1999–2003 up to 19.2 (95% CI 17.4–21.1) per 
100,000 person-years in the time period 2004–2008 (p  ! 
0.001) ( table 1 ). 24.3% of all children with type 1 diabetes 
were less than 5 years old, 32.3% were between the age 
of 5 and 10 years, and the majority of children (53.3%) 
were between the age of 10 and 15 years.  Table 2 a and b 
depicts raw and SIRs by age. Peak incidence rates were 
observed in April, autumn and winter (between 26.6 
and 24.0 per 100,000 person-years) whereas the lowest 
incidence was observed in June (12.1 per 100,000 per-
son-years) ( fig. 1 ).
Time period Population Cases IR (raw)1 SIR (Europe)1
1999–2003 2,615,995 412 15.7 (14.2–17.3) 15.7 (14.2–17.3)
2004–2008 2,215,710 415 18.7 (17.0–20.6) 19.2 (17.4–21.1)
1  Incidence rate (IR) and age-standardized incidence rate (SIR) per 100,000 person-
years (95% CI).
Table 1. A ge-SIR of type 1 diabetes per 
100,000 person-years in the two 5-year 
periods
Table 2.  Age-specific incidence rates of type 1 diabetes per 100,000 person-years: a raw and b standardized by using the European 
standard population
Age group
years
Population Cases
(boys/girls)
Incidence rate
in boys1
Incidence rate
in girls1
Total incidence rate1
a
0–5 1,568,024 202 (121/81) 15.1 (12.5–17.9) 10.6 (8.4–13.0) 12.9 (11.2–14.7)
5–10 1,416,956 267 (130/137) 17.9 (15.0–21.1) 19.8 (16.6–23.3) 18.8 (16.6–21.1)
10–15 1,846,725 358 (198/160) 20.9 (18.1–23.9) 17.8 (15.2–20.7) 19.4 (17.4–21.5)
0–15 4,831,705 827 (449/378) 18.1 (16.5–19.8) 16.1 (14.5–17.8) 17.1 (16.0–18.3)
b
0–5 1,568,024 202 (121/81) 15.1 (12.5–17.9) 10.7 (8.5–13.2) 12.9 (11.2–14.7)
5–10 1,416,956 267 (130/137) 17.7 (14.8–20.9) 19.7 (16.5–23.1) 18.7 (16.5–21.0)
10–15 1,846,725 358 (198/160) 22.1 (19.1–25.3) 19.1 (16.3–22.2) 20.7 (18.6–22.9)
0–15 4,831,705 827 (449/378) 18.4 (16.7–20.1) 16.6 (15.0–18.3) 17.5 (16.3–18.7) 
1 Incidence rate per 100,000 person-years (95% CI).
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 Incidence of Other Types of Diabetes 
 The incidence rate of type 2 diabetes was 0.10 (95% CI 
0.04–0.23) per 100,000 person-years for the time period 
1999–2008. Incidence of MODY was 0.43 (95% CI 0.27–
0.64). MODY 2 (mutation in glucokinase gene) was diag-
nosed in 10 children (48% of all cases with MODY) and 
MODY 3 (mutation in hepatocyte nuclear factor-1  gene) 
was present in 11 children (52%).
 Characteristics at the Time of Diagnosis of Type 1 
Diabetes 
 Mean duration of symptoms like polydipsia and poly-
uria until diagnosis was 2.8  8 2.4 weeks (95% CI 2.6–2.9). 
Mean age at onset of type 1 diabetes was 8.6  8 4.0 years 
(95% CI 8.3–8.8). Mean age at onset was not significantly 
lower (7.7  8 4.3 years; 95% CI 6.3–9.0) in the children 
with parental history of type 1 diabetes. Out of all chil-
dren with newly diagnosed type 1 diabetes, 5.1% had a 
parental history of type 1 diabetes (in 3.5% of cases moth-
ers were affected, in 1.7% of cases fathers were affected). 
9.1% of children had second-degree relatives affected by 
type 1 diabetes. Mean HbA1c was estimated at 11.2  8 
2.6% (95% CI 11.0–11.4) at onset of type 1 diabetes. HbA1c 
was significantly higher in children aged 10–15 years 
(mean HbA1c 11.9  8 2.7%; 95% CI 11.6–12.2%) com-
pared to children under the age of 5 years (mean HbA1c 
10.1  8 1.9%; 95% CI 9.8–10.3%;   1.8%; 95% CI 1.4–2.2%; 
p  ! 0.001).
 Frequency of Ketoacidosis 
 At time of diagnosis, 27.1% of hospitalized children 
were diagnosed with ketoacidosis. The highest propor-
tion of ketoacidosis was found in children under the age 
of 5 years (30.8%), whereas 22.1% of children aged be-
tween 5 and 10 years had ketoacidosis at the time of diag-
nosis. The frequency of ketoacidosis was 28.8% in chil-
dren and adolescents aged 10–15 years. Frequency of ke-
toacidosis was not statistically different between the age 
groups (p = 0.06). There was no difference in frequency 
of ketoacidosis in boys and girls (p = 0.68). In 6.6% of all 
children with newly diagnosed type 1 diabetes, pH was 
 ! 7.1 (severe ketoacidosis). The lowest pH measured at the 
time of diagnosis was 6.8. There were no significant dif-
ferences regarding the frequency of severe ketoacidosis 
across the age groups (8.6% in children under the age of 
5 years, 5.2% in the age group 5–10, and 6.9% in the age 
group 10–15 years; p = 0.38). Neither the incidence of ke-
toacidosis nor the incidence of severe ketoacidosis 
changed between the first and latest 5-year period (p = 
0.14 and p = 0.42). 9.5% of children and adolescents with 
parental history of type 1 diabetes had ketoacidosis com-
pared to 29.3% of children and adolescents without pa-
rental history, which was significantly higher (p = 0.006). 
A total of 9 children (1.1%) were unconscious at the time 
of hospital admission; 8 of these unconscious children 
were older than 8 years of age and 1 was 5 years old. One 
boy aged 1.9 years died from ketoacidosis and cerebral 
edema.
 Mean duration of hospitalization of children with 
newly diagnosed type 1 diabetes was 14.9  8 6.3 days 
(95% CI 14.5–15.4). Mean duration was significantly lon-
ger in 1999 (19.2  8 6.7; CI 17.8–20.5) compared to 2008 
(11.9  8 4.7; CI 10.9–13.0;   7.2; 95% CI 5.6–8.9; p  ! 0.001).
 Discussion 
 Various studies have reported a global increase in the 
incidences of type 1 and type 2 diabetes  [1–7] . We de-
scribe the results from the consecutive Childhood Diabe-
tes Registry accomplished in the federal state of Saxony 
from 1999 to 2008. The registry provided epidemiologi-
cal data on childhood diabetes with a good level of ascer-
tainment. Therefore the registry of Saxony yields a reli-
able estimate of type 1 diabetes in Germany. Age-SIR of 
childhood type 1 diabetes (17.5 per 100,000 per year) in 
Saxony between 1999 and 2008 is similar to previously 
published incidence rates in Germany between 1999 and 
2003 (17.3 per 100,000 per year)  [23] . Divergences may be 
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 Fig. 1. Monthly incidence rates of type 1 diabetes in children aged 
less than 15 years. Mean monthly incidence rates per 100,000 per-
son-years are depicted for the time period 1999–2008. Peak inci-
dence rates were observed in April, autumn and winter. The low-
est incidence was observed in June (12.1 per 100,000 person-
years). 
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due to the difference in survey periods and incidence 
rates may also differ by region. Incidence rates calculated 
by the registry in Baden-Württemberg, southern Germa-
ny, from 1987 to 1998 and 1993 to 1998, ranged between 
12.9 and 14.3 per 100,000 per year  [12, 13] . Between 1999 
and 2003 the incidence rate in Baden-Württemberg was 
15.5 per 100,000  [14] and consequently similar to our cal-
culated incidence rate in Saxony within the same survey 
period (15.7 per 100,000 person-years). Ehehalt et al.  [23] 
reported an increase in incidence by 3.8% per year for the 
period from 1987 to 2003. We also observed a significant 
increase in incidence of type 1 diabetes in Saxony be-
tween the first and latest 5-year period (from 15.7 per 
100,000 person-years in 1999–2003 up to 19.2 per 100,000 
person-years in 2004–2008). Additionally, our estimated 
incidence rates were significantly higher compared to 
those previously assessed in the same region. The registry 
of the former German Democratic Republic reported in-
cidence rates ranging between 7.4 and 13.8 per 100,000 
per year from 1960 until 1989  [15] . There was no registry 
in eastern Germany between 1989 and 1999. Therefore 
the registry of Saxony is currently the only registry in the 
region of the former German Democratic Republic. Life-
style changes over time may account for the increasing 
incidence rates between 1960 and 2006. Environmental 
factors have a significant effect on the pathogenesis of 
type 1 diabetes and may contribute to the increasing in-
cidence rates of our registry compared to previous sur-
veys  [1, 9, 11] .
 Moreover, we found a higher incidence of type 1 dia-
betes in boys, with the highest rate in children under 5 
years. This gender disparity was also observed in other 
European countries  [4, 24, 25] and North America  [10] . 
The underlying pathomechanisms explaining this gen-
der difference are still not clear  [24] . However, recent ob-
servations suggest that the manifestation of disease oc-
curs earlier in boys than girls. No conclusion about the 
shift of incidence rates towards younger children can be 
made from the Saxon registry due to the short observa-
tion period and the lack of epidemiological data in chil-
dren older than 15 years.
 An advantage of this survey is the provision of inci-
dence rates of type 2 diabetes and MODY. To date, there 
are only few epidemiological data on type 2 diabetes and 
MODY in children and adolescents available in Europe. 
We found low incidence rates of type 2 diabetes in chil-
dren under the age of 15 years which is in concordance to 
studies previously published  [16, 18, 26] . Data from the 
USA, comparing Caucasian and Indian children, are in 
accordance with our results, indicating that the preva-
lence of type 2 diabetes is low in Caucasian children and 
adolescents  [26] . However, one important limitation 
should be pointed out. Because our data are based on 
known cases of diabetes only, the incidence of type 2 dia-
betes is probably underestimated especially with respect 
to the increasing prevalence of childhood overweight and 
obesity in Germany  [27] . In comparison to the low inci-
dence of childhood type 2 diabetes, the incidence rate of 
MODY was higher in the Saxon registry compared to 
other surveys  [16–18, 28] . This finding probably suggests 
an underestimated incidence of MODY in other surveys. 
However, geographical differences may also account for 
the various incidence rates. For instance, in France, 
MODY 2 is more prevalent in contrast to England, where 
MODY 3 is more frequent  [28] . Moreover, MODY 3 is 
typically diagnosed in children and adolescents at a later 
age compared to MODY 2  [28] . Therefore, depending on 
the age groups in different surveys, incidence rates may 
vary enormously.
 Data on metabolic characteristics at the time of diag-
nosis of type 1 diabetes revealed very high frequencies of 
ketoacidosis in all children and adolescents and remark-
ably also in very young children: 30.8% of children under 
the age of 5 years had ketoacidosis. Worldwide, great dif-
ferences regarding the frequencies of diabetic ketoacido-
sis are reported  [29–31] . In developing countries the rate 
of ketoacidosis is much higher compared to developed 
countries  [29–31] . Approximately 25% of new patients 
with diabetes present with diabetic ketoacidosis in the 
USA  [30, 31] . In Europe, the frequency of ketoacidosis 
varies between the different geographical regions  [29–
33] . In the region of Parma, Italy, almost 0% of children 
and adolescents present with ketoacidosis at onset of type 
1 diabetes  [31] . This very low incidence was attributed to 
a campaign designed for prevention of primary ketoaci-
dosis in the area of Parma  [31] . In contrast, in Saxony we 
found a higher percentage of ketoacidosis (27.1%). Similar 
findings were reported by Neu et al.  [33] from the registry 
in Baden-Württemberg, Germany, within the same sur-
vey period: 26.3% of children and adolescents with newly 
diagnosed type 1 diabetes presented with ketoacidosis. In 
line with the data from the literature, diabetic ketoacido-
sis is very common in younger children  [34] . The time of 
onset may impact on the rate of future complications 
such as cerebral edema  [31, 32] . Data of the Saxon registry 
may assist in planning public health strategies and may 
support campaigns for primary ketoacidosis prevention 
as currently practiced in Italy  [31] .
 In summary, our data are in agreement with previ-
ously reported incidence rates in Europe. Further re-
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search is needed to identify risk factors and define 
pathomechanisms responsible for the observed increase 
in the incidence of childhood diabetes. Worryingly, dia-
betic ketoacidosis in children and adolescents is still very 
common at the time of diagnosis of type 1 diabetes. Be-
cause of the serious and life-threatening complications of 
diabetic ketoacidosis, prevention by education campaigns 
for the general population and healthcare professionals 
are recommended and further evaluation is needed.
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